Literature DB >> 15898297

Clofazimine as elective treatment for granulomatous cheilitis.

Lourdes Rodríguez Fdez-Freire1, Amalia Serrano Gotarredona, Jose Bernabeu Wittel, Agueda Pulpillo Ruiz, Rocío Cabrera, Manuel Navarrete Ortega, Julián Conejo-Mir.   

Abstract

Cheilitis granulomatosa (CG) is a rare, idiopathic inflammatory disorder that usually affects young adults and clinically is characterized by diffuse, non-tender, soft to firm swelling of one or both lips. A variant of granulomatous cheilitis is Melkersson-Rosenthal syndrome when associated with facial paralysis and furrowed tongue. Several treatments have been used with variable success. We report 3 cases of GC treated with oral clofazimine 100 to 200 mg daily for 3 to 6 months obtaining regression of lesions in all treated cases. Hyperpigmentation and elevation of liver enzymes were observed as side effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15898297

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

Review 1.  Cheilitis granulomatosa: a review.

Authors:  William Austin Critchlow; David Chang
Journal:  Head Neck Pathol       Date:  2013-09-22

2.  Characterizing disease manifestations and treatment outcomes among patients with orofacial granulomatosis in China.

Authors:  Minghui Wei; Cheng Xie; Yubo Liu; Yuhong Wang; Yuanyuan Wang; Xinwen Wang; Yuan Liu
Journal:  JAAD Int       Date:  2020-08-12

Review 3.  Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.

Authors:  Swetalina Pradhan; Bhushan Madke; Poonam Kabra; Adarsh Lata Singh
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.